Related references
Note: Only part of the references are listed.cotH Genes Are Necessary for Normal Spore Formation and Virulence in Mucor lusitanicus
Csilla Szebenyi et al.
MBIO (2023)
Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial
Laurence Millon et al.
CLINICAL INFECTIOUS DISEASES (2022)
Increasing Incidence of mucormycosis in Spanish inpatients from 1997 to 2018
Raul Parra Farinas et al.
MYCOSES (2022)
Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis
Alexandra Serris et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature
Yvette G. T. Loeffen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans
Genna E. Davies et al.
JOURNAL OF FUNGI (2022)
Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing
Qing Zhang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Interferon gamma as an immune modulating adjunct therapy for invasive mucormycosis after severe burn - A case report
Dina M. M. Tawfik et al.
FRONTIERS IN IMMUNOLOGY (2022)
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases
Tempe K. Chen et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective
Alaa M. Elgohary et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Molecular identification of pathogenic fungi in formalin- fixed and paraffin-embedded tissues
Joseph Jillwin et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2021)
Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2021)
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
Anthony J. Carlos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Case Report: Metagenomics Next-Generation Sequencing Can Be Performed for the Diagnosis of Disseminated Mucormycosis
Yi Sun et al.
FRONTIERS IN MEDICINE (2021)
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John et al.
JOURNAL OF FUNGI (2021)
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu et al.
MYCOPATHOLOGIA (2021)
Case Report: Diagnostic Value of Metagenomics Next Generation Sequencing in Intracranial Infection Caused by Mucor
YuChen Liu et al.
FRONTIERS IN MEDICINE (2021)
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Atul Patel et al.
EMERGING INFECTIOUS DISEASES (2021)
Hybrid Imaging of Aspergillus fumigatus Pulmonary Infection with Fluorescent, 68Ga-Labelled Siderophores
Joachim Pfister et al.
BIOMOLECULES (2020)
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
Helene Guegan et al.
JOURNAL OF INFECTION (2020)
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
Abdullah Alqarihi et al.
MBIO (2020)
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
Caleb P. Skipper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
Maria Aigner et al.
JOURNAL OF FUNGI (2020)
Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections
Karen Joy Shaw et al.
JOURNAL OF FUNGI (2020)
Epidemiology and Diagnosis of Mucormycosis: An Update
Anna Skiada et al.
JOURNAL OF FUNGI (2020)
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports
W. Jeong et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies
Olga Rivero-Menendez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology
Philipp Koehler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection
Piriya Kaeopookum et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
Teclegiorgis Gebremariam et al.
SCIENCE ADVANCES (2019)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2019)
Global Epidemiology of Mucormycosis
Hariprasath Prakash et al.
JOURNAL OF FUNGI (2019)
Serial Detection of Circulating Mucorales DNA in Invasive Mucormycosis: A Retrospective Multicenter Evaluation
Toine Mercier et al.
JOURNAL OF FUNGI (2019)
Evaluation of a Novel Mitochondrial Pan-Mucorales Marker for the Detection, Identification, Quantification, and Growth Stage Determination of Mucormycetes
Rita Caramalho et al.
JOURNAL OF FUNGI (2019)
Cutaneous Mucormycosis in Solid Organ Transplant Recipients after Hurricane Harvey: Short- and Long-term Management
Michael Kueht et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2019)
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus
Nathan P. Wiederhold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Molecular Imaging of Invasive Pulmonary Aspergillosis Using ImmunoPET/MRI: The Future Looks Bright
Christopher R. Thornton
FRONTIERS IN MICROBIOLOGY (2018)
Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target
Amanda R. Burnham-Marusich et al.
MSPHERE (2018)
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis
Clara Baldin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples
Nahid Gholinejad-Ghadi et al.
MYCOSES (2018)
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
Frederic Tissot et al.
HAEMATOLOGICA (2017)
Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis
Shane R. Baistrocchi et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
Frederic Tissot et al.
HAEMATOLOGICA (2017)
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
David Grimaldi et al.
LANCET INFECTIOUS DISEASES (2017)
Towards Translational ImmunoPET/MR Imaging of Invasive Pulmonary Aspergillosis: The Humanised Monoclonal Antibody JF5 Detects Aspergillus Lung Infections In Vivo
Genna Davies et al.
THERANOSTICS (2017)
Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates
Jesus Guinea et al.
PLOS ONE (2017)
Drugs in Clinical Development for Fungal Infections
Maria F. Gonzalez-Lara et al.
DRUGS (2017)
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis
A. Kyvernitakis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2016)
ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo
Anna-Maria Rolle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
Teclegiorgis Gebremariam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?
C. Legouge et al.
CLINICAL INFECTIOUS DISEASES (2014)
Nonmolecular Methods for the Diagnosis of Respiratory Fungal Infections
Frederic Lamoth et al.
CLINICS IN LABORATORY MEDICINE (2014)
CotH3 mediates fungal invasion of host cells during mucormycosis
Teclegiorgis Gebremariam et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia
Nikolay N. Klimko et al.
MYCOSES (2014)
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies
Maheen Z. Abidi et al.
MYCOSES (2014)
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R. Kumaresan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications
I. I. Raad et al.
ANNALS OF ONCOLOGY (2013)
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries
Livio Pagano et al.
HAEMATOLOGICA (2013)
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
F. Lanternier et al.
CLINICAL INFECTIOUS DISEASES (2012)
Deferasirox in mucormycosis: hopefully, not defeated
Rajeev Soman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
Brad Spellberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
In vitro activity of Amphotericin B against zygomycetes isolated from deep mycoses: a comparative study between incubation in aerobic and hyperbaric atmosphere
Claudio Farina et al.
MEDICAL MYCOLOGY (2012)
Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
Robyn Neblett Fanfair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
Sarah P. Georgiadou et al.
CLINICAL INFECTIOUS DISEASES (2011)
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
A. Skiada et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2010)
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
Mingfu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
68Ga-Siderophores for PET Imaging of Invasive Pulmonary Aspergillosis: Proof of Principle
Milos Petrik et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Increasing Incidence of Mucormycosis in University Hospital, Belgium
Veroniek Saegeman et al.
EMERGING INFECTIOUS DISEASES (2010)
Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis
Ashraf S. Ibrahim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efficacy of Liposomal Amphotericin B Combined with Gamma Interferon or Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Systemic Zygomycosis in Mice
M. Mar Rodriguez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
Brad Spellberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Zygomycosis in Italy: a Survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)
L. Pagano et al.
JOURNAL OF CHEMOTHERAPY (2009)
Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case-Control Study to Assess Risks for Disease and Outcome
Nina Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997-2006
Dounia Bitar et al.
EMERGING INFECTIOUS DISEASES (2009)
Combination echinocandin-polyene treatment of murine mucormycosis
Ashraf S. Ibrahim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis
Caitlin Reed et al.
CLINICAL INFECTIOUS DISEASES (2008)
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ashraf S. Ibrahim et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Zygomycosis in children: A systematic review and analysis of reported cases
Theoklis E. Zaoutis et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2006)
Posaconazole as salvage therapy for zygomycosis
RN Greenberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia
S Mousset et al.
ANNALS OF HEMATOLOGY (2005)
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice
B Spellberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Interferon-γ and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children
MJ Abzug et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Zygomycosis in the 1990s in a tertiary-care cancer center
DP Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
